Davion Healthcare PLC has provided an important update regarding its share registration in a recent filing. According to the company, as of November 6, 2026, a total of 7,877,590 ordinary shares were registered in the name of Cede & Co., the nominee of The Depository Trust Company (DTC). This disclosure is significant as it reflects the level of shareholder interest and engagement in the company.

Davion Healthcare is categorized under the Surgical & Medical Instruments & Apparatus sector, identified by the Standard Industrial Classification (SIC) code 3841. The company is listed on the Nasdaq under the ticker symbol DAVI. This filing is part of Davion's ongoing effort to maintain transparency with its shareholders and the market.

The filing states, "In response to shareholder enquiries, Davion Healthcare Plc confirms that, according to records provided by its transfer agent, Vstock Transfer LLC, 7,877,590 ordinary shares were registered in the name of Cede & Co., the nominee of The Depository Trust Company (DTC), as of November 6, 2026." This information is crucial as it indicates the registration balance at that date, but does not provide insights into the shares available for sale or lending.

This update may affect various stakeholders, including current and potential investors, as well as analysts monitoring the surgical and medical instruments sector. Understanding share registration details can influence investment decisions and market perceptions.

As for what’s next, the filing does not specify any upcoming actions or additional disclosures related to this matter. Stakeholders will likely await further updates from Davion Healthcare regarding its operational and financial developments.